Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact

Resources

For the latest in biomarkers & precision medicine, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Watch Now

Top R&D Stories of 2023

Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Read Now
Clinical Development

FDA Approves Merck-Developed KEYTRUDA for Non-Small Cell Lung Cancer Therapy

KEYTRUDA demonstrated a clinically meaningful improvement in disease-free survival in patients following surgical resection and platinum-based chemotherapy.
Read More
Biomarker Discovery & Development

Bioassay Optimisation: How the Pandemic Reshaped International Standards for New Therapeutics

The global race to develop, trial, and distribute a vaccine for Covid-19 may have permanently accelerated the development of future therapeutics, including treatments for cancer.
Read More
Clinical Development

FDA Commits to Increasing Diversity in Clinical Trials

The move follows steps announced by the EMA and the MHRA to ensure clinical trials are more reflective of patient populations.
Read More
Clinical Development

Predicting Parkinson’s Disease with Machine Learning

Understanding machine learning’s role in providing a biomarker for the neurological condition.
Read More
Diagnostic Development

Study Reveals Altered Spontaneous Brain Activity in People with Down Syndrome

A new study has revealed that using functional magnetic resonance techniques shows the differences in the spontaneous activity of the brain in people with Down syndrome compared to the general population.
Read More
Diagnostic Development

The Ethical Issues of Pre-Emptive Dementia Diagnosis

If you were at risk of developing Alzheimer’s disease, would you want to know?
Read More
Diagnostic Development

Low-Cost Method for Cancer Testing

The Heatrich-BS assay is a novel low-cost sequencing method for low-cost cancer testing.
Read More
Diagnostic Development

Functional Cure Biomarker for Hepatitis B Virus

Study suggests the haplotype number for hepatitis B virus could act as a predictive biomarker for functional cure during antiviral therapies.
Read More
Diagnostic Development

Can Protein Shapes Indicate Parkinson's Disease?

The first ever potential biomarker for Parkinson’s disease has been discovered.
Read More
Diagnostic Development

Urinary Biomarker Detects Early Onset of Alzheimer’s Disease

Discovery of a new sensitive urinary biomarker could pave the way for cost-effective and large-scale screening of neurodegenerative disease.
Read More
Diagnostic Development

Diagnostic Biomarkers Discovered for Lyme Disease

New hope raised for the early detection and treatment of the tick-borne illness.
Read More
Diagnostic Development

Predicting Heart Disease Risk with ‘Good’ Cholesterol: Is it Still Viable?

A new study analysing the cholesterol levels of black adults challenges traditional perceptions of its role in predicting heart disease risk.
Read More

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers